BRITAIN'S National Institute
for Health and Care Excellence
(NICE) has recommended the
PCSK9 inhibitors alirocumab and
evolocumab for patients with
or mixed dyslipidaemia that is not
controlled with statins.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 10 May 16 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 10 May 16
CHEMIST Warehouse chief operating officer Mario Tascone (pictured above centre) presented Gotcha4Life founders Gus Worland and Gareth Pike with this $450,000 gigantic novelty cheque at an event earlier this week.
NSW Pharmacy Guild President David Heffernan has accused the Royal Australian College of General Practitioners of an “extraordinary attack on community pharmacy,” claiming the doctors’ group appears to see advancing its members as attacking other professions.
THE Pharmacy Practitioner Development Committee (PPDC) has announced the release of new tools to support the implementation of the National Competency Standards Framework for Pharmacists in Australia 2016.